TABLE OF CONTENTS
Clinical Thyroidology June 2012 Entire Issue (PDF File, 3.86 MB, 22 pages )
(Note: the links below open the individual articles in this issue for saving and printing)
- Newer TSH Receptor Antibody Assays May Sometimes Be a Useful Additional Factor for Predicting which Graves’ Patients Will Remain in Remission when Antithyroid Drugs are Stopped
- A Large Nationwide Survey of Patients Hospitalized with Thyroid Storm Has Been Used to Develop a Different Approach to Characterizing the Disease
- Neurodevelopment at 5.5 Years of Age Is Lower in Very Preterm Infants Born of Mothers with Mild TSH Elevation at Term, but Paradoxically, Lower Maternal FT4 Was Associated with Better Neurodevelopment.
- TSH Secreting Tumors Can Be Cured By Long Term Octreotide Treatment
- Subclinical Central Hypothyroidism Can Be Diagnosed by Echocardiography
- The AJCC TNM Staging Underestimates Risk in Young Patients with More Aggressive Differentiated Thyroid Cancer
- A Conservative Approach Based on Measurement of Calcitonin Permits Delay in Surgical Treatment of RET Mutation–Positive Medullary Carcinoma
— Policy Statement on Thyroid Shielding During Diagnostic Medical and Dental Radiology (Updated March 28, 2013)
CLINICAL THYROIDOLOGY, this highly valued abstract and commentary publication provides a broad-ranging look at the clinical thyroid literature. Experts in the field summarize the most cutting-edge, relevant articles that clinicians should know about and provide insight into the relevance and impact of each article on patient care. Please send editorial questions to Dr. Hershman at clinicalthyroidology@thyroid.org.
For a subscription to the online version of CLINICAL THYROIDOLOGY, sign up here.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.